Skip to Main Content (Press Enter)
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
IT
EN
☰
UNIFIND
|
UNIFIND
unisr.it
IT
EN
×
Home
Persone
Pubblicazioni
Facoltà
Ambiti Di Ricerca
☰
Pubblicazioni
THE LANCET ONCOLOGY
Rivista
Codice:
E098908
ISSN:
1470-2045
Dati Generali
Dati Generali
Pubblicazioni (54)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A gap analysis of opportunities and priorities for breast surgical research
Articolo
APX005M, a CD40 monoclonal antibody, for patients with pancreatic adenocarcinoma
Articolo
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial
Articolo
Anal cancer: from an orphan disease to a curable malignancy?
Articolo
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study
Articolo
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Articolo
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up
Articolo
Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial
Articolo
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial
Articolo
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Articolo
Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox
Articolo
CNS prophylaxis for diffuse large B-cell lymphoma
Articolo
Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II tria
Articolo
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial
Articolo
Consensus on molecular imaging and theranostics in prostate cancer
Articolo
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease
Articolo
Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial
Articolo
Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial
Articolo
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Articolo
Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial
Articolo
Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Articolo
Ibrutinib holds promise for patients with 17p deletion CLL
Articolo
Ibrutinib: better combined with other drugs?
Articolo
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
Articolo
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study
Articolo
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial.
Articolo
Justifying vein resection with pancreato-duodenectomy
Articolo
Knowledge gaps in oncoplastic breast surgery
Articolo
Maintenance therapy for metastatic colorectal cancer
Articolo
Molecular imaging targeting carbonic anhydrase 9 in clear-cell renal cell carcinoma: more than meets the eye
Articolo
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
Articolo
Pancreatic cancer: still a cold case?
Articolo
Pancreatic metastasis from leiomyosarcoma of the broad ligament of the uterus.
Articolo
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 study
Articolo
Patience and commitment needed to fight very rare tumours
Articolo
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial
Articolo
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
Articolo
Predictive value of a proteomic signature in patients with non-small-cell lung cancer treated with second-line erlotinib or chemotherapy (PROSE): a biomarker-stratified, randomised phase 3 trial
Articolo
Quality of life after video-assisted surgery for lung cancer.
Articolo
Radiotherapy for renal-cell carcinoma
Articolo
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Articolo
Recommendations for management of patients with neuroendocrine liver metastases
Articolo
Salvage radiotherapy for patients with rising PSA
Articolo
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies
Articolo
Targeted therapies make room, anti-CD79b agents are coming
Articolo
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Articolo
The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer—a multidisciplinary consensus
Articolo
The OligoPanc project: an interdisciplinary expert consensus statement on oligometastatic pancreatic cancer
Articolo
The emerging role of PET-CT scan after radical prostatectomy: still a long way to go
Articolo
The immune system and response to HER2-targeted treatment in breast cancer.
Articolo
The importance of the extent of pelvic-lymph-node dissection in the diagnosis of lymph-node metastases in prostate cancer
Articolo
Thermal ablation versus surgical resection of small-size colorectal liver metastases (COLLISION): an international, randomised, controlled, phase 3 non-inferiority trial
Articolo
Timing of androgen-deprivation therapy for prostate cancer: still a long way to go
Articolo
Whole-brain radiotherapy in primary CNS lymphoma
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
